NCT01135693 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Kent J, Gunasekaran S
Mentally disordered detainees in the police station: the role of the psychiatrist. Advances in Psychiatric Treatment (2010) 16: 115-123. Docking M, Grace K, Bucke T. Police Custody as a "Place of Safety". Examining the Use of Section 136 of the Mental Health Act 1983. Independent Police Complaints Commission, London (2008). Royal College of Psychiatrists. Standards on the Use of Section 136 of the Mental Health Act 1983 (Council Report CR149). Royal College of Psychiatrists, United Kingdom (2008).

A Qualitative Study of Service Users' Perspective of Reasons for Detention Under Section 136 of the Mental Health Act 1983 Using Grounded Theory

Clinical trial NCT01135693 - References